Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Significant results obtained for CRL-5861 in animal model of spinal cord injury

Sep. 21, 2001

New strength of Zomig-ZMT approved by FDA

Sep. 21, 2001

Nonpeptide N/OFQ receptor agonist shows promise for the treatment of anxiety

Sep. 21, 2001

BIIR-561-CL: effects in animal models of neuronal overexcitation

Sep. 21, 2001

Pharmos expands pivotal phase III trial of dexanabinol into U.K.

Sep. 20, 2001

Amgen elects not to develop Guilford's neuroimmunophilin ligands

Sep. 20, 2001

Organon plans to continue development of the Ampakine Org-24448

Sep. 20, 2001

Neurological drugs in Lundbeck's pipeline

Sep. 20, 2001

Lundbeck's psychopharmacological drug pipeline

Sep. 20, 2001

Bradykinin B2 receptor modulators described in patent by Neurogen group

Sep. 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...